부산대학교 도서관

Altieri, B.; Kircher, S.; Herterich, S.; Jahn, A.; Teleanu, M.-V.; Lippert, J.; Landwehr, L.-S.; Kimpel, O.; Reuter, M.; Remde, H.; Stenzinger, A.; Glimm, H.; Bargou, R.C.; Fröhling, S.; Ronchi, C.L.; Appenzeller, S.; Fassnacht, M.; Kroiss, M.

ESMO Open. 11(2)

Cheng, Jeffrey; Faile, Cooper; Krupa, Sam G.

William, D.; Bermúdez, M.; Kübler, A.; Kahlert, C.; Distler, M.; Weitz, J.; Uhrig, S.; Fröhlich, M.; Hutter, B.; Aust, D.; Baretton, G.; Wimberger, P.; Kast, K.; Meisel, C.; Gieldon, L.; Porrmann, J.; Wagner, J.; Arlt, M.; Franke, M.; Fischer, J.; Hackmann, K.; Kreutzfeldt, S.; Mock, A.; Heilig, C.E.; Lipka, D.B.; Teleanu, M.-V.; Schlenk, R.F.; Brors, B.; Hübschmann, D.; Paramasivam, N.; Richter, D.; Beck, K.; Pfütze, K.; Buchhalter, I.; Weichert, W.; Herold, T.; Spiekermann, K.; Jost, P.J.; Keilholz, U.; Klauschen, F.; Bauer, S.; Siveke, J.T.; Kindler, T.; Boerries, M.; Illert, A.L.; Bitzer, M.; Schulze-Osthoff, K.; Schirmacher, P.; Stenzinger, A.; Horak, P.; Heining, C.; Folprecht, G.; Fröhling, S.; Glimm, H.; Schröck, E.; Jahn, A.

ESMO Gastrointestinal Oncology. 9

Berman, John P; Kaboudian, Abouzar; Uzelac, Ilija; Iravanian, Shahriar; Iles, Tinen; Iaizzo, Paul A; Lim, Hyunkyung; Smolka, Scott; Glimm, James; Cherry, Elizabeth M; Fenton, Flavio H

2021 Computing in Cardiology (CinC) Computing in Cardiology (CinC), 2021. 48:1-4 Sep, 2021

Möhrmann, L. ; Werner, M. ; Oleś, M. ; Knol, L. ; Arnold, J.S. ; Mundt, T. ; Paramasivam, N. ; Richter, D. ; Fröhlich, M. ; Hutter, B. ; Hüllein, J. ; Jahn, A. ; Scheffold, C. ; Möhrmann, E.E. ; Hanf, D. ; Kreutzfeldt, S. ; Heilig, C.E. ; Teleanu, M.-V. ; Lipka, D.B. ; Beck, K. ; Baude-Müller, A. ; Jelas, I. ; Rieke, D.T. ; Klotz, L.V. ; Shah, R. ; Herold, T. ; Boerries, M. ; Illert, A.L. ; Allgäuer, M. ; Stenzinger, A. ; Kerle, I.A. ; Horak, P. ; Heining, C. ; Schröck, E. ; Hübschmann, D. ; Fröhling, S. ; Glimm, H.

In ESMO Open April 2025 10(4)

Küchler S; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Brilloff S; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Schäfer S; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Rahimian E; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Kufrin V; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Peri SS; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Musa J; Department of General, Visceral, Thoracic, and Transplant Surgery, University Hospital of Giessen and Marburg, Giessen, Germany.; Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Grünewald TGP; Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Schewe DM; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Ball CR; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.; TU Dresden University of Technology, Faculty of Biology, Dresden, Germany.; Bornhäuser M; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.; Glimm H; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.; Translational Functional Cancer Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bill M; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.; Wurm AA; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany. alexander.wurm@nct-dresden.de.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany. alexander.wurm@nct-dresden.de.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany. alexander.wurm@nct-dresden.de.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany. alexander.wurm@nct-dresden.de.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany. alexander.wurm@nct-dresden.de.

Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE

Illert, A. L.; Stenzinger, A.; Bitzer, M.; Horak, P.; Gaidzik, V. I.; Möller, Y.; Beha, J.; Öner, Ö.; Schmitt, F.; Laßmann, S.; Ossowski, S.; Schaaf, C. P.; Hallek, M.; Brümmendorf, T. H.; Albers, P.; Fehm, T.; Brossart, P.; Glimm, H.; Schadendorf, D.; Bleckmann, A.; Brandts, C. H.; Esposito, I.; Mack, E.; Peters, C.; Bokemeyer, C.; Fröhling, S.; Kindler, T.; Algül, H.; Heinemann, V.; Döhner, H.; Bargou, R.; Ellenrieder, V.; Hillemanns, P.; Lordick, F.; Hochhaus, A.; Beckmann, M. W.; Pukrop, T.; Trepel, M.; Sundmacher, L.; Wesselmann, S.; Nettekoven, G.; Kohlhuber, F.; Heinze, O.; Budczies, J.; Werner, M.; Nikolaou, K.; Beer, A. J.; Tabatabai, G.; Weichert, W.; Keilholz, U.; Boerries, M.; Kohlbacher, O.; Duyster, J.; Thimme, R.; Seufferlein, T.; Schirmacher, P.; Malek, N. P.

Nature Medicine. 29(6):1298-1301

Jahn, A.; Rump, A.; Widmann, T.J.; Heining, C.; Horak, P.; Hutter, B.; Paramasivam, N.; Uhrig, S.; Gieldon, L.; Drukewitz, S.; Kübler, A.; Bermudez, M.; Hackmann, K.; Porrmann, J.; Wagner, J.; Arlt, M.; Franke, M.; Fischer, J.; Kowalzyk, Z.; William, D.; Weth, V.; Oster, S.; Fröhlich, M.; Hüllein, J.; Valle González, C.; Kreutzfeldt, S.; Mock, A.; Heilig, C.E.; Lipka, D.B.; Möhrmann, L.; Hanf, D.; Oleś, M.; Teleanu, V.; Allgäuer, M.; Ruhnke, L.; Kutz, O.; Knurr, A.; Laßmann, A.; Endris, V.; Neumann, O.; Penzel, R.; Beck, K.; Richter, D.; Winter, U.; Wolf, S.; Pfütze, K.; Geörg, C.; Meißburger, B.; Buchhalter, I.; Augustin, M.; Aulitzky, W.E.; Hohenberger, P.; Kroiss, M.; Schirmacher, P.; Schlenk, R.F.; Keilholz, U.; Klauschen, F.; Folprecht, G.; Bauer, Sebastian; Siveke, Jens; Brandts, C.H.; Kindler, T.; Boerries, M.; Illert, A.L.; von Bubnoff, N.; Jost, P.J.; Metzeler, K.H.; Bitzer, M.; Schulze-Osthoff, K.; von Kalle, C.; Brors, B.; Stenzinger, A.; Weichert, W.; Hübschmann, D.; Fröhling, S.; Glimm, H.; Schröck, E.; Klink, B.

Annals of Oncology. 33:1186-1199

Glimm, James; Cheng, Baolian; Sharp, David H.; Kaman, Tulin

Zuljan E; Core Unit Bioinformatics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.; von der Emde B; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Piwonski I; Department of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Pestana A; Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Klinghammer K; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany.; Mock A; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Institute of Pathology, Ludwig-Maximilians-University Munich, München, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Horak P; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Heining C; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.; Klauschen F; Department of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Institute of Pathology, Ludwig-Maximilians-University Munich, München, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.; Pretzell I; West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK), partner site Essen, Essen, Germany.; Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner site Freiburg, a partnership between DKFZ and Medical Center - University of Freiburg, Freiburg, Germany.; Brandts CH; Goethe University Frankfurt, University Hospital, Department of Medicine, Hematology/Oncology & University Cancer Center Frankfurt (UCT), Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt, Frankfurt, Germany.; Kreutzfeldt S; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Teleanu MV; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Hübschmann D; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Morris LGT; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Heiland M; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany.; Department of Oral and Maxillofacial Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Keller U; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany.; Conrad T; Genomics Technology Platform, Berlin Institute of Health at Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Glimm H; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.; Fröhling S; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Ochsenreither S; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany.; Keilholz U; Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany.; Blanc E; Core Unit Bioinformatics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.; Beule D; Core Unit Bioinformatics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.; Rieke DT; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. damian.rieke@charite.de.; Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. damian.rieke@charite.de.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany. damian.rieke@charite.de.; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany. damian.rieke@charite.de.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Glimm, James; Cheng, Baolian; Sharp, David H.; Kaman, Tulin

Heilig, C.E. ; Horak, P. ; Kreutzfeldt, S. ; Teleanu, V. ; Mock, A. ; Renner, M. ; Bhatti, I.A. ; Hutter, B. ; Hüllein, J. ; Fröhlich, M. ; Uhrig, S. ; Süße, H. ; Heiligenthal, L. ; Ochsenreither, S. ; Illert, A.L. ; Vogel, A. ; Desuki, A. ; Heinemann, V. ; Heidegger, S. ; Bitzer, M. ; Scheytt, M. ; Brors, B. ; Hübschmann, D. ; Baretton, G. ; Stenzinger, A. ; Steindorf, K. ; Benner, A. ; Jäger, D. ; Heining, C. ; Glimm, H. ; Fröhling, S. ; Schlenk, R.F.

In ESMO Open December 2021 6(6)

Murthy, A.; Bartocci, E.; Fenton, F. H.; Glimm, J.; Gray, R.; Smolka, S. A.; Grosu, R.

Proceedings of the 9th International Conference on Computational Methods in Systems Biology. :151-160

Bartocci, E.; Cherry, E. M.; Glimm, J.; Grosu, R.; Smolka, S. A.; Fenton, F. H.

Proceedings of the 9th International Conference on Computational Methods in Systems Biology. :103-112

Hamacher, R.W.; Pabst, K.M.; Cheung, P.F.; Heilig, C.E.; Hüllein, J.; Liffers, S-T.; Schaarschmidt, B.M.; Costa, P.; Kessler, L.; Falkenhorst, J.; Glimm, H.; Umutlu, L.; Schuler, M.H.H.; Hübschmann, D.; Bauer, S.; Fröhling, S.; Herrmann, K.; Siveke, J.; Schildhaus, H-U.; Fendler, W.

ESMO Open. 8(1)

Schäfer S; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a Partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Rahimian E; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a Partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany; Department of Pediatric Hematology and Oncology, University Hospital Dresden, Dresden, Germany; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Schmitz-Hübsch L; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a Partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Shaikh M; Laboratory of Hemato-oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic; Faculty of Science, Charles University, Prague, Czech Republic.; Brilloff S; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a Partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany; Department of Pediatric Hematology and Oncology, University Hospital Dresden, Dresden, Germany; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Kufrin V; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a Partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany; Department of Pediatric Hematology and Oncology, University Hospital Dresden, Dresden, Germany; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Küchler S; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a Partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany; Department of Pediatric Hematology and Oncology, University Hospital Dresden, Dresden, Germany; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Fedorova M; Center of Membrane Biochemistry and Lipid Research, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden, Germany.; Kusebauch N; Center of Membrane Biochemistry and Lipid Research, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden, Germany.; Ni Z; Center of Membrane Biochemistry and Lipid Research, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden, Germany.; Helm D; Proteomics Core Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Jeremias I; Department of Pediatrics, Dr. Von Hauner Children's Hospital, LMU University Hospital, LMU Munich, Munich, Germany.; Schewe DM; Department of Pediatric Hematology and Oncology, University Hospital Dresden, Dresden, Germany.; Ball CR; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a Partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany; TUD Dresden University of Technology, Faculty of Biology, Dresden, Germany.; Bornhäuser M; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Glimm H; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a Partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany; Translational Functional Cancer Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Alberich-Jorda M; Laboratory of Hemato-oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic; Childhood Leukaemia Investigation Prague, Department of Pediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague, University Hospital Motol, Prague, Czech Republic.; Bill M; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a Partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.; Wurm AA; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a Partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany; Department of Pediatric Hematology and Oncology, University Hospital Dresden, Dresden, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany. Electronic address: alexander.wurm@nct-dresden.de.

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Hübschmann D; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Innovation and Service Unit for Bioinformatics and Precision Medicine, DKFZ, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Kreutzfeldt S; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Roth B; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Glocker K; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Medical Genetics Center, Munich, Germany.; Schoop J; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Oeser L; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Hausmann S; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Koch C; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Uhrig S; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Hüllein J; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Hutter B; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Fröhlich M; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Heilig CE; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Teleanu MV; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Lipka DB; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Kerle IA; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; DKTK, Partner Site Dresden, Dresden, Germany.; Baude-Müller A; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Beck K; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Heining C; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; DKTK, Partner Site Dresden, Dresden, Germany.; Glimm H; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; DKTK, Partner Site Dresden, Dresden, Germany.; Ückert F; Institute for Applied Medical Informatics, Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Knurr A; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Fröhling S; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Horak P; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany. peter.horak@nct-heidelberg.de.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany. peter.horak@nct-heidelberg.de.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Zech HB; Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Mildred-Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Schafhausen P; 2nd Department of Medicine (Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology) and University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Ramke L; Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Velthaus JL; 2nd Department of Medicine (Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology) and University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Kreutzfeldt S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between German Cancer Research Center (DKFZ) and Heidelberg University Hospital, 01307 Heidelberg, Germany.; Hübschmann D; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between German Cancer Research Center (DKFZ) and Heidelberg University Hospital, 01307 Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, 69120 Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, 69120 Heidelberg, Germany.; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Innovation and Service Unit for Bioinformatics and Precision Medicine, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem Cell Technology and Experimental Medicine, 69120 Heidelberg, Germany.; Rothkamm K; Department of Radiotherapy & Radiation Oncology, Hubertus Wald Tumorzentrum-University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Bokemeyer C; 2nd Department of Medicine (Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology) and University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Hoffmann AS; Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between German Cancer Research Center (DKFZ) and Heidelberg University Hospital, 01307 Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, 69120 Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, 69120 Heidelberg, Germany.; Glimm H; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center Dresden, a Partnership Between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, Dresden University of Technology (TUD), and Helmholtz-Zentrum Dresden-Rossendorf, 01307 Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD, 01069 Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, 01307 Dresden, Germany.; Translational Functional Cancer Genomics, German Cancer Consortium (DKFZ), 69120 Heidelberg, Germany.; Betz CS; Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Kriegs M; Department of Radiotherapy & Radiation Oncology, Hubertus Wald Tumorzentrum-University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; UCCH Kinomics Core Facility, Hubertus Wald Tumorzentrum-University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Christopeit M; 2nd Department of Medicine (Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology) and University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE

Baumann AA; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden,, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany.; Knol LI; National Center for Tumor Diseases (NCT), NCT/UCC Dresden,, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; Arlt M; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany.; Hutschenreiter T; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany.; Richter A; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden,, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany.; Widmann TJ; National Center for Tumor Diseases (NCT), NCT/UCC Dresden,, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENYO), PTS Granada, managed by Fundación Pública Andaluza Progreso y Salud (FPS), Granada, Spain.; Franke M; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany.; Hackmann K; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany.; Winkler S; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; Richter D; National Center for Tumor Diseases (NCT), NCT/UCC Dresden,, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Spier I; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.; Aretz S; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.; Aust D; Institute of Pathology, University Hospital Carl Gustav Carus at TUD Dresden University, Dresden, Germany.; Tumor- and Normal Tissue Bank of the University Cancer Center (UCC), University Hospital Carl Gustav Carus, Medical Faculty, TUD Dresden University of Technology, Dresden, Germany.; Porrmann J; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany.; William D; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany.; Schröck E; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden,, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany.; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Glimm H; National Center for Tumor Diseases (NCT), NCT/UCC Dresden,, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Center for Personalized Oncology, NCT Dresden and University Hospital Carl Gustav Carus, Faculty of Medicine and TUD Dresden University of Technology, Dresden, Germany.; Translational Functional Cancer Genomics, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Jahn A; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany. Arne.Jahn@ukdd.de.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden,, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany. Arne.Jahn@ukdd.de.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany. Arne.Jahn@ukdd.de.; German Cancer Consortium (DKTK), Dresden, Germany. Arne.Jahn@ukdd.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. Arne.Jahn@ukdd.de.

Publisher: Springer Nature in partnership with the Center of Excellence in Genomic Medicine Research at King Abdulaziz University Country of Publication: England NLM ID: 101685193 Publication Model: Electronic Cited Medium: Internet ISSN: 2056-7944 (Electronic) Linking ISSN: 20567944 NLM ISO Abbreviation: NPJ Genom Med Subsets: PubMed not MEDLINE

Murthy, Abhishek; Bartocci, Ezio; Fenton, Flavio H.; Glimm, James; Gray, Richard A.; Cherry, Elizabeth M.; Smolka, Scott A.; Grosu, Radu

IEEE/ACM Transactions on Computational Biology and Bioinformatics IEEE/ACM Trans. Comput. Biol. and Bioinf. Computational Biology and Bioinformatics, IEEE/ACM Transactions on. 10(2):323-336 Apr, 2013